Table 2 Participant characteristics of n = 899
Variable | Mean (SD) or n (%) or Median (IQR) |
|---|---|
Age (years) | 67.0 (12.7) |
Sex (%) | |
 Male | 506 (56.3) |
 Female | 393 (43.7) |
Diabetes type (%) | |
 Type 1 | 83 (9.2) |
 Type 2 | 816 (90.8) |
Diabetes duration (years) | |
 Newly diagnosed | 38 (4.2) |
 1–5 | 183 (20.4) |
 6–10 | 165 (18.4) |
 11–15 | 177 (19.7) |
 16–20 | 99 (11.0) |
  > 20 years | 222 (24.7) |
 Unknown | 15 (1.7) |
Current smoker | |
 Yes | 114 (12.7) |
 No | 785 (87.3) |
Self-reported ideal HbA1c target (mmol/L) | |
  < 7.0 | 349 (38.8) |
 7.0–7.5 | 59 (6.6) |
 7.6–8.0 | 28 (3.1) |
  > 8.0 | 40 (4.4) |
 Don’t know | 423 (47.1) |
IRSD decile (median (IQR)) | 3 (2–4) |
Rurality of residence (ASGC) | |
 Metropolitan (RA1) | 0 (−) |
 Inner regional (RA2) | 571 (63.5) |
 Outer regional (RA3) | 293 (32.6) |
 Remote (RA4) | 26 (2.9) |
 Very remote (RA5) | 9 (1.0) |
State of residence | |
 Tasmania | 443 (49.3) |
 Victoria | 456 (50.7) |
UT Risk Classification | |
 No neuropathy | 351 (39.0) |
 Neuropathy | 149 (16.6) |
 Neuropathy and deformity | 85 (9.5) |
 History of pathology | 122 (13.6) |
 Neuropathic ulcer | 104 (11.6) |
 Acute Charcot | 8 (0.9) |
 Infection | 25 (2.8) |
 Ischaemia | 55 (6.1) |